Mediford Corporation offers comprehensive safety assessment of pharmaceuticals, medical devices, cellular and tissue-based products, cosmetics, agricultural chemicals (including microbial pesticides), food additives, food for specified health uses, drugs intended for animal use, and general chemicals, etc. in compliance with various GLP or other guidelines. We are experienced in administering through various administration routes such as oral, percutaneous, subcutaneous, intravenous, intramuscular, intraperitoneal, intratracheal, intracavity knee joint, etc. Our animal laboratory researchers have received qualifications of junior laboratory animal technician, senior laboratory animal technician, and JACL certified technician in addition to having highly reliable technique through abundant experience and the ability to perform quick and detailed analysis. For pathological examinations, our pathologists with specialized qualifications (JCVP and JSTP, etc.) provide an accurate diagnosis. For cellular and tissue-based products, we are able to offer various GLP-compliant single dose toxicity studies, repeated dose toxicity studies, and tumorigenicity studies (in vivo and in vitro).
Mediford Corporation is SEND* compliant which was mandated since December 2016 for FDA application. The SEND preparation function has been added to our safety system since 2017, which has made quick correspondence possible. In addition, we are collaborating with Fujitsu Limited who have a proven track record with SEND, and, as our global strategies, established a support system with Instem UK. We have built a system that is able to respond to various formats of SEND data material preparation (datasets, define.xml, and n SDRG**). Please feel free to contact us.
